• 1
    Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease. HEPATOLOGY 2005; 42: 4452.
  • 2
    Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960967.
    Direct Link:
  • 3
    Chitturi S, George J. NAFLD/NASH is not just a “Western” problem. In: Farrell GC, Hall P, George J, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorders. London: Blackwell; 2005: 218228.
  • 4
    Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 2002; 35: 373379.
  • 5
    Marchesini G, Marzocchi R, Agostini F, Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005; 16: 421427.
  • 6
    Kim HJ, Kim HJ, Lee KE, Kim D, Kim SK, Ahn CW, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004; 164: 21692175.
  • 7
    Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. HEPATOLOGY 2003; 37: 917923.
  • 8
    Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 2004; 41: 943949.
  • 9
    Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease. J Hepatol 2005; 42: 132138.
  • 10
    George J, Farrell GC. Practical approach to the diagnosis and management of people with fatty liver diseases. In: Farrell GC, Hall P, George J, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorders. London: Blackwell; 2005: 181193.
  • 11
    Hickman I, Powell E, Jonsson J, Ash S. Intensive dietary intervention improves weight maintenance in the management of non-alcoholic fatty liver disease. J Hepatol 2002; 36: 256.
  • 12
    Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103107.
  • 13
    Suzuki A, Lindor K, Saver JS, Lymp J, Mendes F, Muto A, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005; 43: 10601066.
  • 14
    Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004; 53: 413419.
  • 15
    Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005; 100: 10721081.
    Direct Link:
  • 16
    Okita M, Hayashi M, Sasagawa T, Takagi K, Suzuki K, Kinoyama S, et al. Effect of a moderately energy-restricted diet on obese patients with fatty liver. Nutrition 2001; 17: 542547.
  • 17
    Bassuk SS, Manson JE. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol 2005; 99: 11931204.
  • 18
    LaMonte MJ, Blair SN, Church TS. Physical activity and diabetes prevention. J Appl Physiol 2005; 99: 12051213.
  • 19
    Bauman AE. Updating the evidence that physical activity is good for health: an epidemiological review 2000-2003. J Sci Med Sport 2004; 7: 619.
  • 20
    Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537544.
  • 21
    Osland EJ, Powell EE, Banks M, Jonsson JR, Hickman IJ. Obesity management in liver clinics. J Gastroenterol Hepatol 2007; 22: 504509.
  • 22
    Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002; 51: 8994.
  • 23
    Rector RS, Thyfault JP, Morris RT, Laye MJ, Borengasser SJ, Booth FW, et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Gastrointest Liver Physiol 2008; 294: G619G626.
  • 24
    Katsanos CS. Lipid-induced insulin resistance in the liver: role of exercise. Sports Med 2004; 34: 955965.
  • 25
    Lavoie JM, Gauthier MS. Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci 2006; 63: 13931409.
  • 26
    St. George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol 2008. DOI: 10.1111/j.1440-1746.2008.05694.X.
  • 27
    Saris WH, Blair SN, van Baak MA, Eaton SB, Davies PS, Di Pietro L, et al. How much physical activity is enough to prevent unhealthy weight gain? Obesity Rev 2003; 4: 101114.
  • 28
    Marfell-Jones M, Olds T, Steckler A, Carter L. International Standards for Anthropometric Assessment. Potchefstroom, South Africa: ISAK; 2006.
  • 29
    Brown WJ, Trost SG, Bauman A, Mummery K, Owen N. Test-retest reliability of four physical activity measures used in population surveys. J Sci Med Sport 2004; 7: 205215.
  • 30
    ACSM. American College of Sports Medicine's (ACSM) Guidelines for Exercise Testing and Prescription. Philadelphia, PA: Lippincott; 2005.
  • 31
    Armstrong T, Bauman A, Davies J. Physical activity patterns of Australian adults. Results of the 1999 National Physical Activity Survey. Canberra, Australia: Australian Institute of Health and Welfare; 2000.
  • 32
    Stevens J, Truesdale KP, McClain JE, Cai J. The definition of weight maintenance. Int J Obes 2006; 30: 391399.
  • 33
    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393403.
  • 34
    Dishman RK, Buckworth J. Increasing physical activity: a quantitative synthesis. Med Sci Sports Exerc 1996; 28: 706719.
  • 35
    Chitturi S, Weltman M, Farrell GC, McDonald D, Liddle C, Samarasinghe D, et al. HFE mutations, hepatic iron, and fibrosis. HEPATOLOGY 2002; 36: 142149.
  • 36
    Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome. HEPATOLOGY 2002; 35: 367372.
  • 37
    Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G, et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005; 28: 20612063.
  • 38
    Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes. Diabetologia 2007; 50: 949956.
  • 39
    Holt HB, Wild SH, Wareham N, Ekelund U, Umpleby M, Shojaee-Moradie F, et al. Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity. Diabetologia 2007; 50: 16981706.
  • 40
    Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes 2003; 52: 21912197.
  • 41
    Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2005; 90: 31913196.
  • 42
    Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 2007; 30: 683688.
  • 43
    Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. HEPATOLOGY 2008; 47: 11581166.
  • 44
    Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 2007; 92: 34903497.